Manjusha Namuduri - Regeneron Pharmaceuticals, Inc

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 3 Trial Evaluating the Efficacy and Safety of Odronextamab Versus Standard-of-care (SOC) Therapy in Relapsed/refractory (R/R) Aggressive B-cell Non-Hodgkin Lymphoma (B-NHL; OLYMPIA-4)

Eliza Anne Hawkes,Tae Min Kim,Eva Maria Donato Martin,Amanda Nunez-Garcia,Geoffrey Chong,Manjusha Namuduri,Ashish Risal, Yuan Cheng,Dina M. Flink,Min Zhu, Siobhan Nolan,Jurriaan Brouwer-Visser,Aafia Chaudhry,Srikanth R. Ambati,Hesham Mohamed,Seok-Goo Cho

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Phase 3 trial evaluating the efficacy and safety of odronextamab versus standard-of-care (SOC) therapy in relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL; OLYMPIA-4)

Eliza Anne Hawkes,Tae Min Kim,Eva Maria Donato Martín, Amanda Núñez-García,Geoffrey Chong,Manjusha Namuduri,Ashish Risal, Yuan Cheng,Dina M Flink,Min Zhu, Siobhán Nolan,Jurriaan Brouwer-Visser,Aafia Chaudhry,Srikanth R Ambati,Hesham Mohamed,Seok-Goo Cho

Journal of Clinical Oncologyno. 16_suppl (2024)

引用0浏览0引用

Phase 3 Trial Evaluating the Efficacy and Safety of Odronextamab Versus Investigator’s Choice in Previously Untreated Follicular Lymphoma (OLYMPIA-1)

Ruemu Ejedafeta Birhiray,Stefano Luminari,Tae Min Kim,Munci Yagci, Timothy Robert Wassenaar,Ashish Risal,Manjusha Namuduri,Jingxian Cai, Bertha Fearon-Chalet,Min Zhu,Sushmita Mukherjee,Jurriaan Brouwer-Visser,Aafia Chaudhry,Hesham Mohamed,Srikanth R. Ambati,Umberto Vitolo

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Phase 3 Trial Evaluating the Efficacy and Safety of Odronextamab Plus Chemotherapy Versus Rituximab Plus Chemotherapy in Previously Untreated Follicular Lymphoma (OLYMPIA-2)

Colin Hardin, Carl Gray,Silvana Novelli,Tuba Hacibekiroglu,Munci Yagci,Ruemu Ejedafeta Birhiray,Ashish Risal,Manjusha Namuduri,Jingxian Cai,Melanie Ufkin,Min Zhu,Sushmita Mukherjee,Jurriaan Brouwer-Visser,Aafia Chaudhry,Hesham Mohamed,Srikanth R. Ambati,Elzbieta Iskierka-Jazdzewska

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

Phase 3 Trial Evaluating Efficacy and Safety of Odronextamab Plus CHOP Vs Rituximab Plus CHOP in Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL; OLYMPIA-3)

Matthew Matasar,Burhan Turgut,Benoit Tessoulin,Stephanie Guidez,Fevzi Altuntas, Nazia Iqbal,Manjusha Namuduri, Alice Cao,Nickolas Sophos,Amulya Uppala, Katherine Kargus,Min Zhu, Siobhan Nolan,Jurriaan Brouwer-Visser,Aafia Chaudhry,Srikanth R. Ambati,Hesham Mohamed,David Tucker

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

PB2328: TRIAL IN PROGRESS: ATHENA-1 – A PHASE 1 STUDY TO ASSESS SAFETY AND TOLERABILITY OF REGN5837 IN COMBINATION WITH ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

Pim G. N. J. Mutsaers,Jeremy S. Abramson,Manjusha Namuduri,Jingjin LI,Nickolas A. Sophos,Min Zhu,Jurriaan Brouwer-Visser,Hesham Mohamed,Aafia Chaudhry,Andrew J. Davies

HemaSphereno. S3 (2023)

引用0浏览0引用

PB2275: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-2)

Silvana Novelli,Ashish Risal,Manjusha Namuduri,Jingxian Cai,Melanie Ufkin,Min Zhu,Sushmita Mukherjee,Jurriaan Brouwer-Visser,Aafia Chaudhry,Hesham Mohamed,Srikanth Ambati,Elżbieta Iskierka-Jażdżewska

HemaSphereno. S3 (2023)

引用0浏览0引用

Abstract CT129: Trial in Progress: ATHENA-1 - a Phase 1, Open-Label, First-in-human Study to Assess Safety and Tolerability of REGN5837 in Combination with Odronextamab in Patients with Relapsed/refractory Aggressive B-cell Non-Hodgkin Lymphomas

John Baird,Pim G. Mutsaers,Jeremy S. Abramson,Manjusha Namuduri,Jingjin Li,Nickolas A. Sophos,Min Zhu,Jurriaan Brouwer-Visser,Hesham Mohamed,Aafia Chaudhry,Andrew J. Davies

Cancer Researchno. 8_Supplement (2023)

引用2浏览0引用

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

Umberto Vitolo,Elizabeth H. Phillips, Alonso,Michele Merli,Ashish Risal,Manjusha Namuduri,Biyi Shen,Dina Flink,Min Zhu,Sushmita Mukherjee,Jurriaan Brouwer-Visser,Aafia Chaudhry,Hesham Mohamed,Srikanth Ambati,Raul Cordoba

HemaSphereno. S3 (2023)

引用0浏览0引用

PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4)

Eliza A. Hawkes,Tae Min Kim,Manjusha Namuduri,Ashish Risal,Biyi Shen, Dina Flink,Min Zhu, Siobhán Nolan,Jurriaan Brouwer-Visser,Aafia Chaudhry,Srikanth Ambati,Hesham Mohamed,Seok-Goo Cho

HemaSphereno. S3 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn